Peripheral T-cell and NK cell lymphoproliferative disorders

Cell of origin, clinical and pathological implications

Giorgio Inghirami, Wing C. Chan, Stefano Pileri

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Summary: T-cell lymphoproliferative disorders are a heterogeneous group of neoplasms with distinct clinical-biological properties. The normal cellular counterpart of these processes has been postulated based on functional and immunophenotypic analyses. However, T lymphocytes have been proven to be remarkably capable of modulating their properties, adapting their function in relationship with multiple stimuli and to the microenvironment. This impressive plasticity is determined by the equilibrium among a pool of transcription factors and by DNA chromatin regulators. It is now proven that the acquisition of specific genomic defects leads to the enforcement/activation of distinct pathways, which ultimately alter the preferential activation of defined regulators, forcing the neoplastic cells to acquire features and phenotypes distant from their original fate. Thus, dissecting the landscape of the genetic defects and their functional consequences in T-cell neoplasms is critical not only to pinpoint the origin of these tumors but also to define innovative mechanisms to re-adjust an unbalanced state to which the tumor cells have become addicted and make them vulnerable to therapies and targetable by the immune system. In our review, we briefly describe the pathological and clinical aspects of the T-cell lymphoma subtypes as well as NK-cell lymphomas and then focus on the current understanding of their pathogenesis and the implications on diagnosis and treatment.

Original languageEnglish
Pages (from-to)124-159
Number of pages36
JournalImmunological Reviews
Volume263
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Lymphoproliferative Disorders
Natural Killer Cells
T-Lymphocytes
Neoplasms
T-Cell Lymphoma
Chromatin
Immune System
Lymphoma
Transcription Factors
Phenotype
DNA
Therapeutics

Keywords

  • Cell of origin
  • Mechanisms of transformation
  • T-cell lymphoma

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Peripheral T-cell and NK cell lymphoproliferative disorders : Cell of origin, clinical and pathological implications. / Inghirami, Giorgio; Chan, Wing C.; Pileri, Stefano.

In: Immunological Reviews, Vol. 263, No. 1, 01.01.2015, p. 124-159.

Research output: Contribution to journalArticle

@article{a39dfbaa3b4c4a6b802e4f87de9ffa76,
title = "Peripheral T-cell and NK cell lymphoproliferative disorders: Cell of origin, clinical and pathological implications",
abstract = "Summary: T-cell lymphoproliferative disorders are a heterogeneous group of neoplasms with distinct clinical-biological properties. The normal cellular counterpart of these processes has been postulated based on functional and immunophenotypic analyses. However, T lymphocytes have been proven to be remarkably capable of modulating their properties, adapting their function in relationship with multiple stimuli and to the microenvironment. This impressive plasticity is determined by the equilibrium among a pool of transcription factors and by DNA chromatin regulators. It is now proven that the acquisition of specific genomic defects leads to the enforcement/activation of distinct pathways, which ultimately alter the preferential activation of defined regulators, forcing the neoplastic cells to acquire features and phenotypes distant from their original fate. Thus, dissecting the landscape of the genetic defects and their functional consequences in T-cell neoplasms is critical not only to pinpoint the origin of these tumors but also to define innovative mechanisms to re-adjust an unbalanced state to which the tumor cells have become addicted and make them vulnerable to therapies and targetable by the immune system. In our review, we briefly describe the pathological and clinical aspects of the T-cell lymphoma subtypes as well as NK-cell lymphomas and then focus on the current understanding of their pathogenesis and the implications on diagnosis and treatment.",
keywords = "Cell of origin, Mechanisms of transformation, T-cell lymphoma",
author = "Giorgio Inghirami and Chan, {Wing C.} and Stefano Pileri",
year = "2015",
month = "1",
day = "1",
doi = "10.1111/imr.12248",
language = "English",
volume = "263",
pages = "124--159",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Peripheral T-cell and NK cell lymphoproliferative disorders

T2 - Cell of origin, clinical and pathological implications

AU - Inghirami, Giorgio

AU - Chan, Wing C.

AU - Pileri, Stefano

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Summary: T-cell lymphoproliferative disorders are a heterogeneous group of neoplasms with distinct clinical-biological properties. The normal cellular counterpart of these processes has been postulated based on functional and immunophenotypic analyses. However, T lymphocytes have been proven to be remarkably capable of modulating their properties, adapting their function in relationship with multiple stimuli and to the microenvironment. This impressive plasticity is determined by the equilibrium among a pool of transcription factors and by DNA chromatin regulators. It is now proven that the acquisition of specific genomic defects leads to the enforcement/activation of distinct pathways, which ultimately alter the preferential activation of defined regulators, forcing the neoplastic cells to acquire features and phenotypes distant from their original fate. Thus, dissecting the landscape of the genetic defects and their functional consequences in T-cell neoplasms is critical not only to pinpoint the origin of these tumors but also to define innovative mechanisms to re-adjust an unbalanced state to which the tumor cells have become addicted and make them vulnerable to therapies and targetable by the immune system. In our review, we briefly describe the pathological and clinical aspects of the T-cell lymphoma subtypes as well as NK-cell lymphomas and then focus on the current understanding of their pathogenesis and the implications on diagnosis and treatment.

AB - Summary: T-cell lymphoproliferative disorders are a heterogeneous group of neoplasms with distinct clinical-biological properties. The normal cellular counterpart of these processes has been postulated based on functional and immunophenotypic analyses. However, T lymphocytes have been proven to be remarkably capable of modulating their properties, adapting their function in relationship with multiple stimuli and to the microenvironment. This impressive plasticity is determined by the equilibrium among a pool of transcription factors and by DNA chromatin regulators. It is now proven that the acquisition of specific genomic defects leads to the enforcement/activation of distinct pathways, which ultimately alter the preferential activation of defined regulators, forcing the neoplastic cells to acquire features and phenotypes distant from their original fate. Thus, dissecting the landscape of the genetic defects and their functional consequences in T-cell neoplasms is critical not only to pinpoint the origin of these tumors but also to define innovative mechanisms to re-adjust an unbalanced state to which the tumor cells have become addicted and make them vulnerable to therapies and targetable by the immune system. In our review, we briefly describe the pathological and clinical aspects of the T-cell lymphoma subtypes as well as NK-cell lymphomas and then focus on the current understanding of their pathogenesis and the implications on diagnosis and treatment.

KW - Cell of origin

KW - Mechanisms of transformation

KW - T-cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84930324046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930324046&partnerID=8YFLogxK

U2 - 10.1111/imr.12248

DO - 10.1111/imr.12248

M3 - Article

VL - 263

SP - 124

EP - 159

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

IS - 1

ER -